Correct, and they've already started:
In both 8-ks released on Jan 9, aside from cash, percentage of future revs, shares were used as currency.
For Naturally Hemp:
Payment of Consideration . The Structure of the purchase price and payments is as follows:
"(a) Seller (CARSON) received 10,000 Preferred B stock in MEG that was delivered upon closing of the purchase agreement.
(b) Seller (Dunn) received 1,000 Shares of Preferred B stock in MEG that was delivered upon closing of the purchase agreement."
For Skin Scientific:
"(b) 1,175 Shares of Preferred B Stock were issued at closing."
In all cases, "each MEG Preferred B share carries voting and conversion rights equal to 1,000 shares of MEG common stock."
In total, when these shares convert [one year from now, or 6months, I don't know] -- that'll be a total of 12,175,000 shares added alone.
Add that to the OS of 5,264,340 shares, and that's what we're looking at. And, apparently, there are more acquisitions coming.
Overall, it still won't be a bad SS, not at all. However, with each acquisition and shares issued, us (the early investors) get clobbered.
My breakeven here is $1 ... even if revs/profits are good, and debt is dealt will properly - it is highly unlikely it'll reach that level. If lucky, I may get half my investment.
Desperately hoping I'm wrong and this really becomes something special.
